<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7486822\results\search\zoonosis\results.xml">
  <result pre="7486822S2387-0206(20)30427-7 doi: 10.1016/j.medcle.2020.06.012 : Original Article Potential drugâ€&quot;drug interactions in" exact="COVID 19" post="patients in treatment with lopinavir/ritonavirâ˜†Interacciones medicamentosas potenciales en pacientes"/>
  <result pre="19 patients in treatment with lopinavir/ritonavirâ˜†Interacciones medicamentosas potenciales en pacientes" exact="COVID 19" post="en tratamiento con lopinavir/ritonavir Brandariz-NuÃ±ezDavidaâ�ŽCorreas-SanahujaMarcelobGuarcEvaaPicÃ³nRafaelaGarcÃ­aBÃ¡rbaraaGilRocÃ­oa[a], [b], â�ŽCorresponding author. pmc-release:"/>
  <result pre="Abstract Objectives To determine the prevalence of potential interactions in" exact="COVID19" post="patients receiving lopinavir/ritonavir (LPV/r). The secondary objective was to"/>
  <result pre="Cross-sectional and multicenter study with the participation of 2 hospitals." exact="COVID 19" post="patients over 18 years of age, admitted to hospital"/>
  <result pre="factors. Objetivos Determinar la prevalencia de interacciones potenciales en pacientes" exact="COVID19" post="en tratamiento con lopinavir/ritonavir (LPV/r). El objetivo secundario fue"/>
  <result pre="y multicÃ©ntrico con la participaciÃ³n 2 hospitales. Se incluyeron pacientes" exact="COVID 19" post="mayores de 18 aÃ±os, con ingreso hospitalario y en"/>
  <result pre="el nÃºmero de fÃ¡rmacos prescritos. Keywords Potential drugâ€&quot;drug interactions Lopinavir/ritonavir" exact="COVID 19" post="SARS-CoV-2 Protease inhibitor Palabras clave Interacciones medicamentosas potenciales Lopinavir/ritonavir"/>
  <result pre="19 SARS-CoV-2 Protease inhibitor Palabras clave Interacciones medicamentosas potenciales Lopinavir/ritonavir" exact="COVID 19" post="SARS-CoV-2 Inhibidor de la proteasa Introduction COVID-19 is the"/>
  <result pre="currently used in combination with LVP/r for the treatment of" exact="COVID 19," post="also prolong QT, increasing the risk of ventricular arrhythmia"/>
  <result pre="is essential for the comprehensive approach and treatment of the" exact="COVID 19" post="pandemic. Conflict of interests The authors declare no conflict"/>
  <result pre="R, GarcÃ­a B, Gil R. Interacciones medicamentosas potenciales en pacientes" exact="COVID 19" post="en tratamiento con lopinavir/ritonavir. Med Clin (Barc). 2020;155:281â€&quot;287."/>
 </snippets>
</snippetsTree>
